arrow
S

Sean T. Toenjes

Stanford University
H指数:11
被引数:813

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A Type II CDK6 Degrader Enables Cellular Targeting beyond the Limits of Type II Inhibition

II型CDK6降解剂超越了II型抑制的极限,实现了细胞靶向

2026-06-260
OA
A druggable redox switch on SHP1 controls macrophage inflammation

一种可药物调控的SHP1氧化还原开关控制巨噬细胞炎症

2026-03-120
PRE
Engineered antibodies that stabilize drug-modified KRASG12C neoantigens enable selective and potent cross-HLA immunotherapy

工程化抗体能够稳定药物修饰的KRASG12C新抗原,从而实现选择性且高效的跨HLA免疫疗法

2025-12-170
OAAI